Symbol Lookup

Wednesday June 19, 2013 12:00 AM ET. Data delayed 15 minutes.
51.57
0.28 (0.55%)
Bid/Lots
51.56/10
Ask/Lots
51.57/3
Open/Prev Close
51.41/51.29
Day Range
51.11-51.88
52-Week Range
42.25-56.73
Vol/Avg Daily Vol
210.6K/430.5K
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Getting Healthy with Acquisitions, New Products, and Favorable Court Rulings - Research Report on AstraZeneca, Herbalife, CardioNet, Cyberonics, and NuVasive
8:00AM ET on Monday Jun 17, 2013 by PR Newswire

Today, Wall Street Reports announced new research reports highlighting AstraZeneca plc (ADR) (NYSE: AZN), Herbalife Ltd. (NYSE: HLF), CardioNet Inc. (NASDAQ: BEAT), Cyberonics, Inc. (NASDAQ: CYBX) and NuVasive, Inc. (NASDAQ: NUVA). Today's read...

U.S. RESEARCH ROUNDUP: Google, Lennar, Wells Fargo, JPMorgan
6:17PM ET on Wednesday Jun 12, 2013 by Thomson Reuters

June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Google, Lennar and We...

U.S. RESEARCH ROUNDUP: Oracle, Vera Bradley, Macy's, Ciena
6:20PM ET on Thursday Jun 06, 2013 by Thomson Reuters

June 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Oracle and QIWI, on Th...

Analyst Actions: Cyberonics Upgraded to Market Perform at Northland, PT Raised $4; Shares Even Early
8:09AM ET on Thursday Jun 06, 2013 by Midnight Trader
08:09 AM EDT, 06/06/2013 (MidnightTrader) -- Cyberonics, Inc. (CTBX) has been upgraded by analysts at Northland Capital to a Market Perform rating from Underperform. The price target on the stock was raised to $44 from $40 a share. CTBX is stead...
Product Developments, Partnerships and Validated Clinical Trials Help Diversify Today's Treatments - Research Report on Varian, Align Technology, Volcano, Wright Medical Group, and Cyberonics
8:00AM ET on Thursday Jun 06, 2013 by PR Newswire

Editor Note: For more information about this release, please scroll to bottom.

Today, Wall Street Reports announced new research reports highlighting Varian Medical Systems Inc. (NYSE: VAR), Align Technology Inc. (NASDAQ: ALGN), Volcano ...

Company Information

Cyberonics, Inc. (Cyberonics) is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters for each patient; instruction manuals, and magnets to suspend or induce stimulation manually. The VNS Therapy pulse generator and lead are surgically implanted into patients generally during an outpatient procedure. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and software and a tunneling tool.

CONTACT INFORMATION

HeadquartersThe Cyberonics Building
100 Cyberonics Boulevard
HOUSTON, TX, United States 77058
Phone281-228-7200
Fax281-218-9332

EXECUTIVE OFFICERS

President, Chief Executive Officer, DirectorDaniel Moore
Chief Financial Officer, Senior Vice President - FinanceGregory Browne
Senior Vice President, Chief Administrative Officer, SecretaryDavid Wise
Senior Vice President - Research & DevelopmentMilton Morris
Chief Compliance Officer, Vice President, General Counsel, Assistant SecretaryDarren Alch

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • Standard & Poor's Stock Report

    Standard & Poor's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$1.4BBeta0.84
Revenue (TTM)$254.3MEPS$1.65
Shares Out.27.6MBook Value$8.29
Dividend Yield0.00%P/E31.0x
Annual Dividend Rate$0.00Price/Sales (TTM)5.6
Ex-Div Date1/1/01P/Cash Flow (TTM)27.7x
Pay Date1/1/01Operating Margin29.21%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample